LOTEMP PLUS

This brand name is authorized in Nigeria.

Active ingredients

The drug LOTEMP PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen
2	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0594	Tablet	LOTEMP PLUS TABLETS TAB 200 mg; 325 mg 10 X 10	24 RNW-PP-303711 LOTEMP PLUS TABLETS IBUPROFEN 200 MG + PARACETAMOL 325 MG TABLET Each Tablet contains: Paracetamol BP 325mg, Ibuprofen BP 200 mg, Maize starch BP 28 mg, Croscarmellose Sodium BP 6 mg, Methyl Paraben BP 1.12 mg, Propyl Paraben BP 0.28 mg, Microcrystalline Cellulose BP 11.84 mg, Colloidal Silicon dioxide BP 2.36 mg, Purified Talc BP 4.8 mg, Magnesium Stearate BP 0.6 mg A11-0594 Drugs Nigerian Products 1010 OTC 12/28/2022 UNIQUE PHARMACEUTICALS LIMITED, FATAI ATERE WAY MATORI, MUSHIN LAGOS LAGOS 8097421000 mail@uniquepharm.com UNIQUE PHARMACEUTICALS LIMITED, 11, FATAI ATERE WAY, MATORI, MUSHIN, LAGOS., Nigeria	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BE51	Paracetamol, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0594